Literature DB >> 11711057

Treatment with dehydroepiandrosterone sulfate increases NMDA receptors in hippocampus and cortex.

S Wen1, K Dong, J P Onolfo, M Vincens.   

Abstract

Our aim was to investigate if the memory-enhancing effects reported for dehydroepiandrosterone sulfate in rodents could be mediated through modulation of NMDA receptors. Using autoradiography we studied the effect of dehydroepiandrosterone sulfate, administered for 5 days (30 mg/kg, i.p. twice a day), on NMDA binding sites labelled with [3H]dizocilpine ([3H]MK801) in rat brain. Dehydroepiandrosterone sulfate treatment significantly increased the [3H]MK801 binding sites in hippocampal areas (field CA1, CA3, dentate gyrus lateral blade and medial blade) and in cortex layer IV as compared to the control group. These results demonstrate for the first time the ability of dehydroepiandrosterone sulfate to increase the number of NMDA binding sites in rat brain, an action that could be of interest for therapeutic application.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711057     DOI: 10.1016/s0014-2999(01)01383-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Enhancement of Cognitive and Electrophysiological Measures of Hippocampal Functioning in Rats by a Low, But Not High, Dose of Dehydroepiandrosterone Sulfate (DHEAS).

Authors:  David M Diamond
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-10

2.  Acute Effects of Oral Dehydroepiandrosterone on Counterregulatory Responses During Repeated Hypoglycemia in Healthy Humans.

Authors:  Maia Mikeladze; Maka S Hedrington; Nino Joy; Donna B Tate; Lisa M Younk; Ian Davis; Stephen N Davis
Journal:  Diabetes       Date:  2016-08-02       Impact factor: 9.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.